Scott Randal W.

CIK 00013378014 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001337801

Recent Transactions

50 trades

Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-02-17$75.93/sh−3,307→ 11,589 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2026-02-17−10,000→ 31,501 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-02-17$16.75/sh+10,000→ 21,589 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-02-17$75.57/sh−4,793→ 14,896 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2026-02-17$74.34/sh−1,900→ 19,689 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-11-17−10,000→ 41,501 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-11-17$66.25/sh−3,801→ 17,788 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-11-17$16.75/sh+10,000→ 21,589 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-11-17$66.89/sh−6,199→ 11,589 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-20+6,589→ 11,589 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-06-04$31.30/sh−1,500→ 4,000 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-06-03$29.48/sh−200→ 5,500 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-06-03$28.68/sh−800→ 5,700 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-03-01$34.00/sh−2,500→ 6,500 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-12-18$40.00/sh−2,000→ 9,000 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-12-01$28.50/sh−1,000→ 12,500 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-12-01$30.00/sh−1,500→ 11,000 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-09-05$30.00/sh−2,500→ 13,500 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 total
Award
Talis Biomedical Corp$TLIS
Stock option (right to buy)
2023-06-09+95,000→ 95,000 total
Award
Invitae Corp
Stock Option (right to buy)
2023-04-27+86,705→ 86,705 total
Award
Invitae Corp
Stock Option (right to buy)
2023-04-27+28,901→ 28,901 total
Award
Invitae Corp
Common Stock
2023-04-27+70,422→ 161,222 total
Award
Invitae Corp
Common Stock
2022-07-16+45,325→ 82,325 total
Award
Invitae Corp
Employee Stock Option (right to buy)
2022-07-16+22,730→ 22,730 total
Award
Invitae Corp
Common Stock
2022-07-16+8,475→ 90,800 total
Award
Invitae Corp
Employee Stock Option (right to buy)
2022-07-16+4,275→ 4,275 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2022-06-22+104,921→ 104,921 total
Award
Talis Biomedical Corp$TLIS
Stock Option (right to buy)
2022-06-10+95,000→ 95,000 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2021-06-17+38,895→ 38,895 total
Purchase
Talis Biomedical Corp$TLIS
Common stock
2021-05-17$10.11/sh+11,000→ 20,000 total
Purchase
Talis Biomedical Corp$TLIS
Common stock
2021-05-14$10.16/sh+9,000→ 9,000 total
Conversion
Talis Biomedical Corp$TLIS
Series E-1 Preferred Stock
2021-02-17−478,402→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Series F-1 Preferred Stock
2021-02-17−432,749→ 0 total
Conversion
Talis Biomedical Corp$TLIS
Series D-1 Preferred Stock
2021-02-17−1,076,643→ 0 total
Purchase
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17$16.00/sh+312,500→ 312,500 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+302,621→ 1,390,064 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+334,546→ 1,087,443 total
Conversion
Talis Biomedical Corp$TLIS
Common Stock
2021-02-17+752,897→ 752,897 total
Purchase
BridgeBio Pharma, Inc.$BBIO
Common Stock
2021-02-17$62.50/sh+16,000→ 21,000 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2020-06-23+101,223→ 101,223 total
Sale
Invitae Corp
Common Stock
2019-08-26$24.82/sh−28,301→ 3,450,669 total
Sale
Invitae Corp
Common Stock
2019-08-26$24.02/sh−11,699→ 3,478,970 total
Sale
Invitae Corp
Common Stock
2019-05-28$17.60/sh−30,000→ 3,490,669 total
Award
Invitae Corp
Stock Option (right to buy)
2019-05-02+10,000→ 10,000 total
Sale
Invitae Corp
Common Stock
2019-02-25$19.08/sh−29,000→ 3,521,669 total
Sale
Invitae Corp
Common Stock
2019-02-25$19.66/sh−1,000→ 3,520,669 total
Award
Invitae Corp
Employee Stock Option (right to buy)
2018-06-22+10,000→ 10,000 total

Companies

Recent Filings

Address

C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250

PALO ALTO, CA, 94304

View on SEC.gov